Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force-Reference-Cited by-同舟云学术

Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

Published:2016-03 Issue:2 Volume:19 Page:125-137
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Marsh Kevin,IJzerman Maarten,Thokala Praveen,Baltussen Rob,Boysen Meindert,Kaló Zoltán,Lönngren Thomas,Mussen Filip,Peacock Stuart,Watkins John,Devlin Nancy

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference115 articles.

1. Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force;Thokala;Value Health,2016

2. Dodgson J, Spackman M, Pearman A, Phillips L. Multi-criteria analysis: amanual. 2009. Available from: http://www.communities.gov.uk/documents/corporate/pdf/1132618.pdf. [Accessed September 13, 2015].

3. Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing;Phillips;Ann Oper Res,2007

4. A socio-technical approach for group decision support in public strategic planning: the Pernambuco PPA case;Bana e Costa;Group Decis Negot,2014

5. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature;Marsh;Pharmacoeconomics,2014

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review;Critical Reviews in Oncology/Hematology;2024-10

2. Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients;Journal of Cancer Policy;2024-09

3. Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment;PharmacoEconomics - Open;2024-08-28

4. Unravelling Elements of Value of Healthcare and Assessing their Importance Using Evidence from Two Discrete-Choice Experiments in England;PharmacoEconomics;2024-07-31

5. Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol;PharmacoEconomics - Open;2024-07-09